Skip to the page

Data / Drug companies / Caplin Steriles Limited

Caplin Steriles Limited: 88 products in the FDA NDC directory, labeler code 65145

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Caplin Steriles Limited (labeler code 65145) lists 88 products in the FDA National Drug Code Directory, covering 41 finished drugs by generic name. By type: 88 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 17, 2026.

The request: Watch Caplin Steriles Limited (FDA labeler code 65145): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
65145
Products in commercial distribution
88
Packages
91
Finished drugs by generic name
41
Prescription products
88
Over the counter products
0
Flagged as original packager
85 of 85 products that carry the flag
Started marketing in the last 12 months
27
Earliest marketing start
April 30, 2021
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)88100%

Products by type

TypeProductsShare
Prescription drugs88100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Injection3236.4%
Injection, solution3236.4%
Solution/ drops1011.4%
Solution78%
Injection, solution, concentrate33.4%
Injection, suspension22.3%
Emulsion11.1%
Injection, emulsion11.1%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Potassium phosphates65145-196Injection, solution, concentrateGeneric drugs (ANDA)September 17, 2026
Potassium phosphates65145-195Injection, solution, concentrateGeneric drugs (ANDA)September 17, 2026
Potassium phosphates65145-194Injection, solution, concentrateGeneric drugs (ANDA)September 17, 2026
Nicardipine Hydrochloride65145-198InjectionGeneric drugs (ANDA)June 25, 2026
Nicardipine Hydrochloride65145-197InjectionGeneric drugs (ANDA)June 25, 2026
Milrinone Lactate in 5% Dextrose65145-177Injection, solutionGeneric drugs (ANDA)June 25, 2026
Milrinone Lactate in 5% Dextrose65145-176Injection, solutionGeneric drugs (ANDA)June 25, 2026
Foscarnet Sodium65145-191Injection, solutionGeneric drugs (ANDA)May 20, 2026
Calcium Gluconate65145-172Injection, solutionGeneric drugs (ANDA)May 13, 2026
Calcium Gluconate65145-171Injection, solutionGeneric drugs (ANDA)May 13, 2026
Calcium Gluconate65145-170Injection, solutionGeneric drugs (ANDA)May 13, 2026
Phenylephrine hydrochloride65145-117InjectionGeneric drugs (ANDA)April 28, 2026
Phenylephrine hydrochloride65145-116InjectionGeneric drugs (ANDA)April 28, 2026
Phenylephrine hydrochloride65145-115InjectionGeneric drugs (ANDA)April 28, 2026
Argatroban65145-126InjectionGeneric drugs (ANDA)April 17, 2026
Prochlorperazine Edisylate65145-119InjectionGeneric drugs (ANDA)April 8, 2026
Desmopressin Acetate65145-184Injection, solutionGeneric drugs (ANDA)March 16, 2026
Desmopressin Acetate65145-183Injection, solutionGeneric drugs (ANDA)March 16, 2026
Sodium phosphates65145-202Injection, solutionGeneric drugs (ANDA)March 10, 2026
Sodium phosphates65145-201Injection, solutionGeneric drugs (ANDA)March 10, 2026
Sodium phosphates65145-200Injection, solutionGeneric drugs (ANDA)March 10, 2026
Methylprednisolone Acetate65145-193Injection, suspensionGeneric drugs (ANDA)February 6, 2026
Methylprednisolone Acetate65145-192Injection, suspensionGeneric drugs (ANDA)February 6, 2026
Etomidate65145-128Injection, solutionGeneric drugs (ANDA)February 5, 2026
Etomidate65145-127Injection, solutionGeneric drugs (ANDA)February 5, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.